Novo Nordisk | Fremdkapital



Loan Capital Veränderung Datum
ANI Pharmaceuticals USD 611.63M 3.29M 2025-03
Aurora Cannabis CAD 41.68M 542K 2024-12
Bausch Health Companies USD 21.23B 2.29B 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 96.31B 44.86B 2025-03
Novo Nordisk DKK 51.45B 156M 2024-09
Pacira USD 381.29M 2.26M 2025-03
Perrigo USD 3.58B 730.9M 2024-12
Prestige Brands USD 1.01B 16.93M 2025-03
Sanofi 13.41B 1.62B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 5.23B 7M 2025-03



Novo Nordisk Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.